Skip to main content
. Author manuscript; available in PMC: 2020 Mar 29.
Published in final edited form as: Circ Res. 2019 Mar 29;124(7):1061–1070. doi: 10.1161/CIRCRESAHA.118.312156

Figure 3.

Figure 3.

Relation between baseline plasma renin, aldosterone, and the serum aldosterone and renin concentration (ARR) ratio and the home systolic blood pressure response to spironolactone in the PATHWAY-2 study.

Reference: Williams B, MacDonald TM, Morant SV, Webb DJ, Sever P, McInnes GT, Ford I, Cruickshank JK, Caulfield MJ, Padmanabhan S, Mackenzie IS, Salsbury J, Brown MJ. Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies. Lancet Diabetes Endocrinol. 2018;6(6):464-475. doi: 10.1016/S2213-8587(18)30071-8.